Blood Gas and Electrolyte Analyzer Market to Reach US$ 5.7 Bn by 2030 | CAGR 9%

Rise in awareness of blood gas and electrolyte analyzers and increasing geriatric population are some of the key drivers for the growth of the blood gas and electrolyte analyzer market. Other factors such as technological advancements in products, thereby increasing efficiency and accuracy, are also crucial aspects that will affect market growth in a positive way. One such advancement is portable blood gas and electrolyte analyzers, which have greatly enhanced convenience and ease of access of the product.

Click HERE To Get A SAMPLE (Including Full TOC, Table & Figures) At-

Based on a Fact.MR study, the leading product type in the market is blood gas analyzers owing to their popularity and wide array of applications in the healthcare sector. The market has witnessed increased demand of these analyzers across hospitals, clinics, etc., thereby boosting overall growth. As such, the blood gas and electrolyte analyzer market is projected to expand at an impressive CAGR of around 9% though 2030..

Key Takeaways from Brachytherapy Devices Market Study

  • North America is the dominant region and accounted for US$ 363 million in market value in 2019.
  • Hospitals are the leading end user segment, and will hold 60% of the total market share.
  • Cervical cancer is the leading indication segment of the market, with an average of 500,000 females getting diagnosed every year.
  • The applicators segment of the global brachytherapy devices market is set to expand at a growth rate of 8.4%.
  • The brachytherapy devices market is in a state of consolidation, where key players account for over 70% of the market revenue.
  • North America holds the largest share in the brachytherapy devices market. This is predominantly due to rise in cancer cases and convenient insurance policies laid out by healthcare sector in the region. Factors such as research & development of brachytherapy devices with new and advanced technologies also helps this regional market to do well in this space.

Need More Information About Report Methodology? Click Here-

“The COVID-19 pandemic has resulted in reduced hospital visits for other ailments, which is having a slight negative impact on the growth of the brachytherapy devices market,” says a Fact.MR analyst.

Technological Advancements Key to Market Growth

Key players such as Elekta AB and Accuray are investing in the research & developments of brachytherapy devices – image-guided brachytherapy (IBT), etc., which is one of the latest technologies introduced in the market. Other competitors are also adapting and expanding their portfolios pertaining to such technologies. This has become one of the leading factors that will significantly affect market revenue and increase competition among players in the brachytherapy devices market landscape.

Full Access Of This Exclusive Report Is Available At-

More Valuable Insights on Brachytherapy Devices Market

Fact.MR, in its new offering, presents an unbiased analysis of the global brachytherapy devices market, presenting historical demand data (2015-2019) and forecast statistics for the period of 2022-2030. The study divulges essential insights on the brachytherapy devices market on the basis of type (brachytherapy afterloaders, brachytherapy applicators {intracavitary, interstitial and others}), indication (cervical cancer, prostate cancer, breast cancer, skin cancer & others), dose rate (high dose rate, low dose rate, pulse dose rate, and others), and end user (hospitals, cancer treatment centers, and others), across major regions of the world (North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa).

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.


US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: [email protected]